GevRx Nutraceuticals, Inc. filed a Form D with the Securities and Exchange Commission on 2026-09-18.
GevRx Nutraceuticals, Inc. filed a Form D notice of an exempt securities offering with the SEC on September 18, 2026. The filing reports $300K sold. Its industry group is Biotechnology. It names James Christopher (President, Secretary and Treasurer), Douglas Spiel, M.D. (Chief Executive Officer and Chief Medical Director), Mary Esposito (Director) (SEC Form D, September 18, 2026).
GevRx Nutraceuticals, Inc. raised on Sep 18. 125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Selling to GevRx Nutraceuticals, Inc.? See who runs it and how to reach them, plus this week's 25 other newly funded companies.
Is this your company?
Sell to companies like GevRx Nutraceuticals, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-09-18 · the record
Pitching, partnering or investing alongside them? See who really runs and owns GevRx Nutraceuticals, Inc.
Free to see. No signup.
More on the people and the money behind GevRx Nutraceuticals, Inc., from the filings we hold.
Biotechnology raises by companies based in New York, filed in September 2026, largest first.
Get an email when GevRx Nutraceuticals, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when GevRx Nutraceuticals, Inc. raises, hires or launches. No email unless you switch it on.
Watch GevRx Nutraceuticals, Inc. →Get the full cited report on GevRx Nutraceuticals, Inc.
What the filing shows about GevRx Nutraceuticals, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on GevRx Nutraceuticals, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives GevRx Nutraceuticals, Inc.'s address as 20 Marble Loop, Suite 2A, Staten Island, NY 10309.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on GevRx Nutraceuticals, Inc. See pricing
GevRx Nutraceuticals, Inc. is a registered filer with the SEC (CIK 2156105) and has filed since 2026-09-18. 1 filing is on record, the latest on 2026-09-18.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
GevRx Nutraceuticals, Inc.'s Form D of 2026-09-18 names James Christopher, Douglas Spiel, M.D., Mary Esposito and 2 more as its officers, directors or promoters.
Its new offerings report $300K sold across 1 offering, as its own filings state.
Trailing twelve months. 771 filings in Biotechnology, totalled by week. The dot is this raise, $300K, on the same scale — one filing against the whole group's total, so it sits low by construction.
While no offering proceeds are set aside for payments to the named officers or directors, it is possible that some proceeds to be used as working capital will be used indirectly for paying salaries to employees including executive officers.
On the filing as: Executive Officer, Director.
James Christopher is named as President, Secretary and Treasurer on the Form D that GevRx Nutraceuticals, Inc. filed with the SEC on 18 September 2026, one of 5 people that filing names.
On the filing as: Executive Officer, Director.
Douglas Spiel, M.D. is named as Chief Executive Officer and Chief Medical Director on the Form D that GevRx Nutraceuticals, Inc. filed with the SEC on 18 September 2026, one of 5 people that filing names.
Mary Esposito is named as Director on the Form D that GevRx Nutraceuticals, Inc. filed with the SEC on 18 September 2026, one of 5 people that filing names.
On the filing as: Executive Officer.
Dylan Spiel is named as Vice President on the Form D that GevRx Nutraceuticals, Inc. filed with the SEC on 18 September 2026, one of 5 people that filing names.
On the filing as: Executive Officer.
Michael Betley, Ph.D. is named as Chief Scientific Officer on the Form D that GevRx Nutraceuticals, Inc. filed with the SEC on 18 September 2026, one of 5 people that filing names.
5 people named on the filing — 4 holding an executive role and 1 as a director only.
Named as of the 2026-09-18 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about GevRx Nutraceuticals, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on GevRx Nutraceuticals, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on GevRx Nutraceuticals, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist GevRx Nutraceuticals, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind GevRx Nutraceuticals, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for GevRx Nutraceuticals, Inc.. With no account yet, you sign up free and land on the result.
On these lists: New York raises, week of 2026-09-14 · Biotech raises, week of 2026-09-14 · Biotech raises in New York
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/gevrx-nutraceuticals-inc-form-d-101304